Hematology

Top Story

Hospitalization for heart failure may predict VTE risk

February 4, 2016

Heart failure may serve as an independent risk factor for venous thromboembolism among hospitalized patients, according to the results of a systematic review and meta-analysis.

Patients at an increased risk for VTE should be treated with thromboprophylaxis, the researchers wrote.

Meeting News Coverage

Top Takeaways from ASH: CAR T-cell therapy poised to shift hematologic malignancies treatment paradigm

February 3, 2016
Building on research momentum and attention in the field of hematology over the past several years, chimeric antigen receptor T-cell therapy took center stage at the…
In the Journals

Rivaroxaban appears safe, effective in routine clinical practice

January 28, 2016
Oral rivaroxaban appeared safe and effective compared with standard anticoagulation therapy for the treatment of symptomatic deep vein thrombosis, according to the…

Mount Sinai Hospital launches program to improve transitions of care for patients with VTE

January 27, 2016
Pfizer and Bristol-Myers Squibb have awarded independent 2-year grants to the department of medicine at Icahn School of Medicine at Mount Sinai Hospital for the…
CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Meeting News CoverageVideo

VIDEO: Eltrombopag increases hematologic response in severe aplastic anemia

January 13, 2016
More »
Featured
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
In the Journals

Hospitalization for heart failure may predict VTE risk

February 4, 2016
Heart failure may serve as an independent risk factor for venous thromboembolism among hospitalized patients, according to the results of a…
Meeting News Coverage

Top Takeaways from ASH: CAR T-cell therapy poised to shift hematologic malignancies treatment paradigm

February 3, 2016
Building on research momentum and attention in the field of hematology over the past several years, chimeric antigen receptor T-cell therapy took…
In the Journals

Rivaroxaban appears safe, effective in routine clinical practice

January 28, 2016
Oral rivaroxaban appeared safe and effective compared with standard anticoagulation therapy for the treatment of symptomatic deep vein thrombosis…

Mount Sinai Hospital launches program to improve transitions of care for patients with VTE

January 27, 2016
Pfizer and Bristol-Myers Squibb have awarded independent 2-year grants to the department of medicine at Icahn School of Medicine at Mount Sinai…
In the Journals

Algorithm reliable, safe for diagnostic management of DVT

January 21, 2016
An algorithm that combines whole-leg and limited compression ultrasonography appeared to be a reliable and safe tool for the diagnostic management of…
In the Journals

Early diagnosis, chemotherapy response influence renal survival in LCDD

January 20, 2016
Early diagnosis and treatment of light chain deposition disease is essential to delay progression to end-stage renal disease and prevent recurrence…
In the Journals

Sirolimus shows promise for pediatric ALPS

January 15, 2016
Treatment with sirolimus led to durable complete responses in children with refractory multi-lineage autoimmune cytopenias, according to the results…
CME

The Patient with Severe Leukocytosis

January 15, 2016 Expires: 1/15/2017
Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML). Although imatinib has been the…
In the Journals

Society releases consensus statement on management of cardio-oncology patients in cath labs

January 13, 2016
There are an estimated 14.5 million cancer survivors in the United States, a number that is expected to grow to 20 million by 2020. However, there is…
Meeting News CoverageVideo

VIDEO: Eltrombopag increases hematologic response in severe aplastic anemia

January 13, 2016
ORLANDO, Fla. — Mrinal S. Patnaik, MBBS, offers perspective on a late-breaking abstract from the ASH Annual Meeting and Exposition that showed…
More Headlines »
morganatic-roan